KPT πŸ“ˆ KP Tissue - Overview

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA48265Y1043

KPT: Tissues, Towels, Napkins

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Metro, White Swan, White Cloud, Embassy, Satinelle, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada. Web URL: https://www.kptissueinc.com

Additional Sources for KPT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

KPT Stock Overview

Market Cap in USD 58m
Sector Consumer Defensive
Industry Household & Personal Products
GiC Sub-Industry Personal Care Products
IPO / Inception

KPT Stock Ratings

Growth 5y 15.4%
Fundamental -11.7%
Dividend 71.5%
Rel. Strength Industry -119
Analysts -
Fair Price Momentum 8.33 CAD
Fair Price DCF 13.58 CAD

KPT Dividends

Dividend Yield 12m 11.04%
Yield on Cost 5y 13.01%
Annual Growth 5y 0.00%
Payout Consistency 95.4%

KPT Growth Ratios

Growth Correlation 3m -32.5%
Growth Correlation 12m 6.1%
Growth Correlation 5y 24.4%
CAGR 5y 3.33%
CAGR/Mean DD 5y 0.22
Sharpe Ratio 12m -0.30
Alpha -15.73
Beta 0.43
Volatility 12.98%
Current Volume 14.3k
Average Volume 20d 12.9k
What is the price of KPT stocks?
As of December 22, 2024, the stock is trading at CAD 8.15 with a total of 14,300 shares traded.
Over the past week, the price has changed by -0.86%, over one month by -0.86%, over three months by -2.40% and over the past year by -2.64%.
Is KP Tissue a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, KP Tissue is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -11.74 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KPT as of December 2024 is 8.33. This means that KPT is currently overvalued and has a potential downside of 2.21%.
Is KPT a buy, sell or hold?
KP Tissue has no consensus analysts rating.
What are the forecast for KPT stock price target?
According to ValueRays Forecast Model, KPT KP Tissue will be worth about 9.1 in December 2025. The stock is currently trading at 8.15. This means that the stock has a potential upside of +11.66%.
Issuer Forecast Upside
Wallstreet Target Price 9.1 12%
Analysts Target Price - -
ValueRay Target Price 9.1 11.7%